A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

A randomized, open-label, single dosing, two-way crossover clinical trial to compare the safety/tolerability and pharmacokinetics of the combination of Cilnidipine 10mg and Valsartan 160mg in comparison to each component coadministered in healthy male volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: IlDong Pharmaceutical Co Ltd
• Treatments: Cilnidipine; Valsartan

Criteria

Inclusion Criteria:

• Age between 20 and 40

• Signed informed consent

Exclusion Criteria:

• Has a history of hypersensitivity to IP ingredients

• Hypertension or hyportension